240 related articles for article (PubMed ID: 8419606)
1. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
Weintrub PS; Wara DW; Duliege AM
J Pediatr; 1993 Jan; 122(1):163-4. PubMed ID: 8419606
[No Abstract] [Full Text] [Related]
2. The role of aerosol pentamidine prophylaxis.
Ong EL
Int J STD AIDS; 1993; 4(2):67-9. PubMed ID: 8476968
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized pentamidine prophylaxis of Pneumocystis carinii pneumonia.
Wilkinson SB
Am J Med; 1995 Apr; 98(4):422-3. PubMed ID: 7709963
[No Abstract] [Full Text] [Related]
4. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
Edge MD; Rimland D
AIDS; 1999 May; 13(8):991-2. PubMed ID: 10371182
[No Abstract] [Full Text] [Related]
5. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E
AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236
[No Abstract] [Full Text] [Related]
6. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Bucher HC; Griffith L; Guyatt GH; Opravil M
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
[TBL] [Abstract][Full Text] [Related]
9. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
[TBL] [Abstract][Full Text] [Related]
10. Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV-infected children.
Schuval SJ; Bonagura VR
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):876-9. PubMed ID: 8044270
[No Abstract] [Full Text] [Related]
11. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
12. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
13. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
JAMA; 1991 Apr; 265(13):1637-40, 1643-4. PubMed ID: 1672167
[No Abstract] [Full Text] [Related]
14. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
James CW; McNelis KC; Szabo S
Am J Health Syst Pharm; 2003 Aug; 60(15):1572-4. PubMed ID: 12951757
[No Abstract] [Full Text] [Related]
15. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidine.
Teuscher AU; Opravil M; Theiler R; Speich R; Kuster H; Siegenthaler W; Russi EW; Lüthy R
Clin Infect Dis; 1993 Apr; 16(4):519-22. PubMed ID: 8513058
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.
Drug Ther Bull; 1994 Feb; 32(2):12-5. PubMed ID: 7654282
[TBL] [Abstract][Full Text] [Related]
18. The relative efficacy of oral dapsone and nebulized pentamidine as prophylaxis for Pneumocystis carinii pneumonia.
Sabin CA; Phillips AN
AIDS; 1993 Mar; 7(3):440. PubMed ID: 8471213
[No Abstract] [Full Text] [Related]
19. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
[TBL] [Abstract][Full Text] [Related]
20. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
Castellano AR; Nettleman MD
JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
